載入...
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience
PURPOSE. This study measured the time taken for setting up the different facets of Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO), an international phase III study being conducted in 44 participating countries. METHODS. Time to regulatory authority (RA) approval, time to ethics...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3579596/ https://ncbi.nlm.nih.gov/pubmed/23359433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0342 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|